MedTrace Logo

Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC)

NCT00317070 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2009-05-11

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the efficacy and tolerability of the intravesical cocktail and its comparison with intravesical DMSO in a controlled trial for the treatment of painful bladder syndrome including interstitial cystitis.

Conditions

  • Interstitial Cystitis
  • Bladder Diseases

Interventions

DRUG

dimethyl sulfoxide

intravesical installation 50 ml

DRUG

IC Cocktail

* Heparin 10,000 units * Gentamicin 80 mg * Hydrocortisone sodium succinate (Solucortef) 100 mg * Lidocaine hydrochloride 1% 10 ml * Sodium Bicarbonate 8.4% 5 ml

Sponsors & Collaborators

  • Nova Scotia Health Authority

    lead OTHER

Principal Investigators

  • Jerzy Gajewski, MD, FRCSC · Nova Scotia Health Authority

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00317070 on ClinicalTrials.gov